Yüklüyor......

AICAR TREATMENT REDUCES INTERSTITIAL FIBROSIS IN AGING MICE Suppression of the Inflammatory Fibroblast

In 2030, elderly people will represent 20% of the United States population. Even now, chronic cardiac diseases, especially heart failure with preserved systolic function (HFpEF), are the most expensive DRGs for Medicare. Progressive interstitial fibrosis in the aging heart is well recognized as an i...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Mol Cell Cardiol
Asıl Yazarlar: Cieslik, Katarzyna A., Trial, JoAnn, Entman, Mark L.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2017
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5600709/
https://ncbi.nlm.nih.gov/pubmed/28826664
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.yjmcc.2017.08.003
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!